Skip to main content
MDLNMedline Inc.Hold5.6·$32.21-0.54%

Medline (MDLN) Q2 2026 earnings — TrendMatrix coverage

BEAT+55.8% vs estimateEPS $0.50 vs $0.32 estCurrent verdict Hold 5.6/10

Reported

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure

Event detail · Q2 2026

Key numbers

Reported EPS
$0.50
Estimate
$0.32
Surprise
+55.8%
Revenue (period 2026-06-27)
$7.68B
Score today
5.6/10

Revenue source: mixed.

Report record · Q2 2026

How the report landed

Medline (MDLN) beat the $0.32 estimate with diluted EPS of $0.50 — a large 55.8% upside surprise.

Current read · as of 2026-09-14

Where TrendMatrix's rating stands now

TrendMatrix currently rates MDLN Hold at 5.6/10; no pre/post engine snapshot brackets this report.

3 of the last 3 quarters beat the estimate; this quarter's +55.8% surprise compares with a +32.7% four-quarter average. Next scheduled report: 2026-11-04.

What supports the rating

  • Sector modifier (Healthcare): +0.5
  • Strong earnings beat streak (3/4)

What argues against it

  • Concentration risk — Customer: Vizient Supply, HealthTrust Purchasing Group, and Premier Healthcare Alliance (GPOs) (69.0%)
  • V7 low-quality RISK_OFF penalty: -0.5 (Q=4.2)
  • Negative momentum

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current engine read

The levels TrendMatrix's engine tracks

Current price
$32.21
Price target
$40.14
Stop
$30.91
Upside to target
+24.6%
Reward-to-risk
3.0:1

The stock trades at 40.7× trailing but 20.5× forward earnings — consensus estimates already build in a substantial earnings recovery.

Model outputs from TrendMatrix’s engine as of 2026-09-14 — shown for context, not personalized investment advice.

Healthcare context

MDLN at TrendMatrix's latest read

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry
Medical Instruments & Supplies
Market cap
$43.77B
P/E (fwd)
20.5
P/E (ttm)
40.7
52-week range
$31.87$50.88
Off 52-week high
36.7%
RSI (14)
41
Volume vs avg
0.72×
Score today
5.6/10

Earnings figures are sourced from TrendMatrix’s pipeline (EPS: existing earnings extraction; revenue: SEC XBRL company facts where available, yfinance-provisional otherwise). Not a buy/sell rating, a price target, or investment advice — see the current verdict on the stock’s main page for TrendMatrix’s live read.

Home Stocks MDLN Earnings Q2 2026 earnings